Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? U.K. Prospective Diabetes Study 61

Diabetes Care

Volumn 25, Issue 8, 2002, Pages 1410-1417

  Colagiuri, Stephen ^a   Cull, Carole A ^b   Holman, Rury R ^b  

^a PRINCE OF WALES HOSPITAL   (Australia)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; GLYCOSYLATED HEMOGLOBIN;

ARTICLE; BLOOD GLUCOSE MONITORING; CLINICAL FEATURE; CONTROLLED STUDY; DIABETES CONTROL; DIABETIC RETINOPATHY; DISEASE COURSE; EARLY DIAGNOSIS; ERECTILE DYSFUNCTION; GLUCOSE BLOOD LEVEL; HEART INFARCTION; HEMOGLOBIN DETERMINATION; HUMAN; MAJOR CLINICAL STUDY; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PERCEPTIVE THRESHOLD; RISK ASSESSMENT; SAMPLE SIZE; STROKE; SYMPTOM; AGED; BLOOD; DIET RESTRICTION; DISEASE FREE SURVIVAL; FEMALE; HYPERGLYCEMIA; MALE; MIDDLE AGED; PREDICTION AND FORECASTING; PROSPECTIVE STUDY; TREATMENT OUTCOME;

AGED; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; DISEASE-FREE SURVIVAL; FASTING; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERGLYCEMIA; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 0036674992     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.25.8.1410     Document Type: Article

References (20)

1. Gu K, Cowie CC, Harris MI: Mortality in adults with and without diabetes in a national cohort of the US population, 1971-1993. Diabetes Care 21:1138-1145, 1998
2. UKPDS 23: Risk factors for coronary artery disease in non-insulin dependent diabetes. BMJ 316:823-828, 1998
3. Harris MI: Undiagnosed NIDDM: clinical and public health issues. Diabetes Care 16:642-652, 1993
4. UKPDS 6: Complications in newly diagnosed type 2 diabetic patients and their association with different clinical and biochemical risk factors. Diabetologia 13:1-11, 1990
5. Harris MI, Klein R, Welborn TA, Knuiman MW: Onset of NIDDM occurs at least 4-7 years before clinical diagnosis. Diabetes Care 15:815-819, 1992
6. UKPDS Group: UK Prospective Diabetes Study 30: Diabetic retinopathy at diagnosis of type 2 diabetes and associated risk factors. Arch Ophthalmol 116:297-303, 1998
7. UKPDS Group: UK Prospective Diabetes Study VIII: Study design, progress and performance. Diabetologia 34:877-890, 1991
8. UKPDS Group: Microaneurysms in the development of diabetic retinopathy (UK-PDS 42). Diabetologia 42:1107-1112, 1999
9. UKPDS Group: UK Prospective Diabetes Study XI: Biochemical risk factors in type 2 diabetic patients at diagnosis compared with age-matched normal subjects. Diabet Med 11:534-544, 1994
10. Cull CA, Manley SE, Stratton IM, Neil HA, Ross IS, Holman RR, Turner RC, Matthews DR: Approach to maintaining comparability of biochemical data during long-term clinical trials. Clin Chem 43:1913-1918, 1997
11. UKPDS Group: Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352:837-853, 1998
12. SAS Institute: Statistical Analysis System. Cary, NC, SAS Institute, 1990
13. World Health Organization: Diabetes Mellilus: Report of a WHO Study Group. Geneva, World Health Org., 1985 (Tech. Rep. Ser., no. 727)
14. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC: Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-419, 1985
15. UKPDS Group: UK Prospective Diabetes Study 16: Overview of six years' therapy of type 2 diabetes: a progressive disease. Diabetes 44:1249-1258, 1995
16. Levy J, Atkinson AB, Bell PM, McCance DR, Haddon DR: Beta-cell deterioration determines the onset and rate of progression of secondary dietary failure in type 2 diabetes mellitus: the 10-year follow-up of the Belfast Diet Study. Diabet Med 15:290-296, 1998
17. Schneider H, Ehrlich M, Lischinski M, Schneider F: Bewirkte das flächendeckende Glukosurie-Screening der 60er und 70er Jahre im Osten Deutschlands tatsächlich den erhofften Prognosevorteil für die frühzeitig entdeckten Diabetiker? Diabetes und Stoffwechsel 5:33-38, 1996
18. Engelgau MM, Narayan KMV, Herman WH: Screening for type 2 diabetes. Diabetes Care 23:1563-1580, 2000
19. The Decode Study Group: Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria. Lancet 354:617-621, 1999
20. Wareham NJ, Griffin SJ: Should we screen for type 2 diabetes? Evaluation against National Screening Committee criteria. BMJ 322:986-988, 2001